Exhibit 1

AGREEMENT

The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.

Date: December 9, 2024

NAN FUNG GROUP HOLDINGS LIMITED
By:	/s/ Tang Chun Wai Nelson
	Name: Tang Chun Wai Nelson
	Title:  Director
NF INVESTMENT HOLDINGS LIMITED
By:	/s/ Tang Chun Wai Nelson
	Name: Tang Chun Wai Nelson
	Title:  Director
NAN FUNG LIFE SCIENCES HOLDINGS LIMITED
By:	/s/ Sun Xintong
	Name: Sun Xintong
	Title:  Director
NFLS PLATFORM HOLDINGS LIMITED
By:	/s/ Sun Xintong
	Name: Sun Xintong
	Title:  Director
NFLS BETA LIMITED
By:	/s/ Sun Xintong
	Name: Sun Xintong
	Title:  Director
PIVOTAL LIFE SCIENCES HOLDINGS LIMITED
By:	/s/ Sun Xintong
	Name: Sun Xintong
	Title:  Director

PIVOTAL PARTNERS LTD
By:	/s/ Sun Xintong
	Name: Sun Xintong
	Title:  Director
PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD
By:	/s/ Robert Hopfner
	Name: Robert Hopfner
	Title:  Director
PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.
By:	PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD
	Its General Partner,
By:	/s/ Robert Hopfner
	Name: Robert Hopfner
	Title:  Authorized Signatory
PIVOTAL BIOVENTURE PARTNERS FUND I, L.P.
By:	PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.
	Its General Partner,
By:	PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD
	Its General Partner,
By:	/s/ Robert Hopfner
	Name: Robert Hopfner
	Title:  Authorized Signatory